Here's the failing.
During the Zoom session, SG said they had been unsure which to choose as the primary endpoint, cognition or depression.
So the primary endpoint should have been "either cognitive improvement or depression improvement or both".
That would have required a larger sample size for the same power of test.
Hold, held
Ann: ACW June 2024 quarterly activity report & Appendix 4C, page-19
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $60.36M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.1¢ | 1.9¢ | $58.10K | 2.927M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 4183265 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 1815831 | 7 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| ACW (ASX) Chart |